Share Price and Basic Stock Data
Last Updated: October 18, 2025, 6:37 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Shree Renuka Sugars Ltd operates in the sugar industry and reported a market capitalization of ₹6,411 Cr. The company’s sales showed a fluctuating trend, with quarterly sales reaching ₹2,552 Cr in December 2022 and peaking at ₹3,376 Cr in March 2024. However, the revenue declined to ₹2,691 Cr in March 2025. The total revenue from operations for the trailing twelve months (TTM) stood at ₹9,871 Cr, reflecting a recovery from previous years. The company’s sales have experienced a slight increase compared to ₹9,017 Cr in March 2023, which indicates a potential stabilization in demand. Despite this, the operating profit margin (OPM) remained weak, recorded at -4%, showcasing the challenges faced in controlling costs. The cash conversion cycle (CCC) reported at -5 days suggests efficient management of working capital, although the overall financial health remains concerning due to high expenses. The fluctuating sales figures and negative operating margins highlight the volatility in the sugar market, which could be influenced by factors such as raw material prices and regulatory changes.
Profitability and Efficiency Metrics
Shree Renuka Sugars Ltd’s profitability metrics indicate significant challenges, with a net profit of ₹-300 Cr for the fiscal year 2025, down from ₹-197 Cr in March 2023. The company reported an interest coverage ratio (ICR) of 0.89x, suggesting that operating income is barely sufficient to cover interest expenses. The return on capital employed (ROCE) improved to 11% in March 2025, up from 10% in the previous year, indicating some operational efficiency gains despite the overall losses. The operating profit for March 2025 was ₹601 Cr, reflecting a marginal increase from ₹590 Cr in March 2023. However, the net profit margin remained negative at -2.74%, highlighting ongoing profitability issues. The company’s earnings per share (EPS) for March 2025 was ₹-1.41, a decline from ₹-0.93 in the previous year. These figures underscore the urgent need for Shree Renuka to enhance its operational efficiency and cost management strategies to return to profitability.
Balance Sheet Strength and Financial Ratios
The financial health of Shree Renuka Sugars Ltd is concerning, with total borrowings amounting to ₹5,889 Cr against reserves of ₹-1,888 Cr, indicating a highly leveraged position. The company’s debt-to-equity ratio stood at -3.50x, which is alarmingly high, reflecting an unsustainable capital structure. The current ratio was reported at 0.59x, suggesting liquidity issues, as it is below the industry benchmark of 1.0x. Furthermore, the quick ratio of 0.10x indicates that the company may struggle to meet short-term obligations. The book value per share, including revaluation reserves, was at ₹-7.87, indicating significant losses relative to its equity. The enterprise value (EV) was reported at ₹11,665.44 Cr, which translates to an EV/EBITDA ratio of 16.02x, suggesting that the market may be pricing in future recovery potential despite current losses. Overall, the balance sheet reflects a precarious position, necessitating a rigorous financial restructuring to stabilize operations.
Shareholding Pattern and Investor Confidence
Shree Renuka Sugars Ltd’s shareholding pattern reveals a stable commitment from promoters, who hold 62.48% of the company’s shares. This level of promoter ownership can be seen as a stabilizing factor for investor confidence. However, foreign institutional investors (FIIs) have decreased their stake to 3.37% from a higher 4.08% in September 2022, indicating a cautious sentiment among international investors. Domestic institutional investors (DIIs) slightly increased their stake to 10.16%, while public shareholders account for 23.97%, reflecting a diversified ownership structure. The total number of shareholders has grown to 8,02,293, suggesting an increasing interest in the company despite its financial challenges. This increase in shareholder count may indicate a belief in potential turnaround strategies. However, the declining FII interest could raise concerns about the stock’s attractiveness in the broader market context.
Outlook, Risks, and Final Insight
If margins sustain improvements, Shree Renuka Sugars Ltd could potentially enhance its profitability metrics, particularly through better cost management and operational efficiency. However, significant risks remain, including high leverage, liquidity constraints, and fluctuating sugar prices, which may impact revenue stability. The company’s ability to manage its borrowings effectively will be crucial in navigating financial challenges. Additionally, if the negative sentiment among FIIs persists, it could hinder access to capital for growth initiatives. Conversely, if the domestic market for sugar continues to expand and operational efficiencies are realized, there may be opportunities for recovery. Stakeholders should monitor the company’s strategic initiatives and financial restructuring plans closely, as these could dictate the future trajectory of its performance in the competitive sugar industry.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Shree Renuka Sugars Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gayatri Sugars Ltd | 111 Cr. | 15.0 | 21.4/7.02 | 694 | 11.4 | 0.00 % | 36.6 % | % | 10.0 |
| Dhampure Speciality Sugars Ltd | 71.6 Cr. | 85.9 | 142/82.0 | 23.2 | 41.0 | 0.00 % | 11.6 % | 8.88 % | 10.0 |
| Dhampur Bio Organics Ltd | 517 Cr. | 78.0 | 141/57.3 | 152 | 1.60 % | 3.97 % | 1.56 % | 10.0 | |
| DCM Shriram Industries Ltd | 1,513 Cr. | 174 | 214/142 | 17.4 | 103 | 1.15 % | 13.7 % | 11.8 % | 2.00 |
| Davangere Sugar Company Ltd | 496 Cr. | 3.47 | 12.9/3.03 | 43.9 | 2.45 | 0.00 % | 6.70 % | 3.17 % | 1.00 |
| Industry Average | 1,794.64 Cr | 265.39 | 53.38 | 229.21 | 0.65% | 8.62% | 7.89% | 6.37 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,953 | 2,188 | 2,552 | 2,328 | 2,284 | 2,555 | 3,055 | 3,376 | 3,054 | 2,566 | 2,603 | 2,691 | 2,010 |
| Expenses | 1,901 | 2,142 | 2,344 | 2,070 | 2,213 | 2,491 | 2,822 | 3,118 | 2,970 | 2,339 | 2,605 | 2,400 | 2,096 |
| Operating Profit | 52 | 46 | 207 | 259 | 71 | 64 | 233 | 258 | 84 | 227 | -2 | 292 | -86 |
| OPM % | 3% | 2% | 8% | 11% | 3% | 3% | 8% | 8% | 3% | 9% | -0% | 11% | -4% |
| Other Income | 17 | 16 | 12 | 42 | 71 | 10 | 7 | 10 | 21 | 12 | 32 | 61 | 10 |
| Interest | 124 | 134 | 144 | 190 | 214 | 217 | 244 | 243 | 214 | 211 | 194 | 192 | 193 |
| Depreciation | 58 | 60 | 60 | 60 | 64 | 64 | 69 | 69 | 69 | 70 | 70 | 70 | 72 |
| Profit before tax | -113 | -132 | 15 | 50 | -137 | -207 | -74 | -44 | -178 | -41 | -234 | 91 | -341 |
| Tax % | 1% | 7% | 4% | 12% | 1% | -1% | 133% | 152% | -7% | -44% | -13% | -2% | -23% |
| Net Profit | -114 | -142 | 14 | 45 | -139 | -206 | -172 | -111 | -166 | -23 | -204 | 93 | -264 |
| EPS in Rs | -0.53 | -0.66 | 0.07 | 0.20 | -0.65 | -0.96 | -0.81 | -0.52 | -0.78 | -0.10 | -0.96 | 0.43 | -1.24 |
Last Updated: August 20, 2025, 3:40 am
Below is a detailed analysis of the quarterly data for Shree Renuka Sugars Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 2,010.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,691.00 Cr. (Mar 2025) to 2,010.00 Cr., marking a decrease of 681.00 Cr..
- For Expenses, as of Jun 2025, the value is 2,096.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2,400.00 Cr. (Mar 2025) to 2,096.00 Cr., marking a decrease of 304.00 Cr..
- For Operating Profit, as of Jun 2025, the value is -86.00 Cr.. The value appears to be declining and may need further review. It has decreased from 292.00 Cr. (Mar 2025) to -86.00 Cr., marking a decrease of 378.00 Cr..
- For OPM %, as of Jun 2025, the value is -4.00%. The value appears to be declining and may need further review. It has decreased from 11.00% (Mar 2025) to -4.00%, marking a decrease of 15.00%.
- For Other Income, as of Jun 2025, the value is 10.00 Cr.. The value appears to be declining and may need further review. It has decreased from 61.00 Cr. (Mar 2025) to 10.00 Cr., marking a decrease of 51.00 Cr..
- For Interest, as of Jun 2025, the value is 193.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 192.00 Cr. (Mar 2025) to 193.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 72.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 70.00 Cr. (Mar 2025) to 72.00 Cr., marking an increase of 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -341.00 Cr.. The value appears to be declining and may need further review. It has decreased from 91.00 Cr. (Mar 2025) to -341.00 Cr., marking a decrease of 432.00 Cr..
- For Tax %, as of Jun 2025, the value is -23.00%. The value appears to be improving (decreasing) as expected. It has decreased from -2.00% (Mar 2025) to -23.00%, marking a decrease of 21.00%.
- For Net Profit, as of Jun 2025, the value is -264.00 Cr.. The value appears to be declining and may need further review. It has decreased from 93.00 Cr. (Mar 2025) to -264.00 Cr., marking a decrease of 357.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is -1.24. The value appears to be declining and may need further review. It has decreased from 0.43 (Mar 2025) to -1.24, marking a decrease of 1.67.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:27 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11,546 | 10,088 | 9,849 | 11,844 | 6,250 | 4,504 | 4,876 | 5,645 | 6,431 | 9,017 | 11,320 | 10,907 | 9,871 |
| Expenses | 10,622 | 10,290 | 10,132 | 11,474 | 8,865 | 5,879 | 4,816 | 5,074 | 6,030 | 8,427 | 10,634 | 10,298 | 9,439 |
| Operating Profit | 925 | -202 | -284 | 370 | -2,614 | -1,376 | 60 | 571 | 401 | 590 | 685 | 609 | 432 |
| OPM % | 8% | -2% | -3% | 3% | -42% | -31% | 1% | 10% | 6% | 7% | 6% | 6% | 4% |
| Other Income | -568 | 27 | 80 | 377 | 528 | 111 | 2,823 | 74 | 61 | 59 | 37 | 119 | 115 |
| Interest | 959 | 922 | 976 | 958 | 519 | 560 | 511 | 384 | 393 | 591 | 918 | 811 | 790 |
| Depreciation | 1,076 | 991 | 776 | 955 | 240 | 221 | 211 | 209 | 208 | 238 | 266 | 280 | 283 |
| Profit before tax | -1,679 | -2,089 | -1,956 | -1,166 | -2,846 | -2,046 | 2,161 | 52 | -139 | -180 | -462 | -363 | -526 |
| Tax % | -12% | -13% | -8% | -1% | -23% | -0% | 10% | 325% | -1% | 10% | 36% | -17% | |
| Net Profit | -1,479 | -1,814 | -1,809 | -1,152 | -2,204 | -2,037 | 1,950 | -117 | -137 | -197 | -627 | -300 | -397 |
| EPS in Rs | -22.02 | -19.52 | -19.48 | -12.19 | -8.89 | -7.56 | 10.95 | -0.54 | -0.65 | -0.93 | -2.95 | -1.41 | -1.87 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -22.65% | 0.28% | 36.32% | -91.32% | 7.58% | 195.73% | -106.00% | -17.09% | -43.80% | -218.27% | 52.15% |
| Change in YoY Net Profit Growth (%) | 0.00% | 22.93% | 36.04% | -127.64% | 98.90% | 188.15% | -301.73% | 88.91% | -26.70% | -174.48% | 270.43% |
Shree Renuka Sugars Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 17% |
| 3 Years: | 19% |
| TTM: | -18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 39% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 26% |
| 3 Years: | -15% |
| 1 Year: | -35% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 1:30 pm
Balance Sheet
Last Updated: September 10, 2025, 2:29 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 67 | 93 | 93 | 95 | 192 | 192 | 192 | 213 | 213 | 213 | 213 | 213 |
| Reserves | -564 | -2,435 | -1,856 | -3,437 | -1,899 | -3,199 | -1,074 | -875 | -821 | -1,094 | -1,651 | -1,888 |
| Borrowings | 9,560 | 8,897 | 9,104 | 9,875 | 7,851 | 2,902 | 3,093 | 4,447 | 5,234 | 5,569 | 5,794 | 5,889 |
| Other Liabilities | 3,887 | 4,412 | 6,174 | 6,060 | 3,854 | 9,730 | 4,460 | 3,122 | 2,477 | 2,917 | 5,807 | 4,620 |
| Total Liabilities | 12,951 | 10,967 | 13,515 | 12,592 | 9,998 | 9,624 | 6,670 | 6,907 | 7,103 | 7,604 | 10,163 | 8,833 |
| Fixed Assets | 7,970 | 6,008 | 7,702 | 7,587 | 6,192 | 4,023 | 3,886 | 3,776 | 4,004 | 4,296 | 4,561 | 4,493 |
| CWIP | 32 | 33 | 37 | 35 | 29 | 100 | 142 | 7 | 217 | 114 | 50 | 21 |
| Investments | 167 | 85 | 86 | 121 | 108 | 19 | 19 | 60 | 43 | 42 | 34 | 40 |
| Other Assets | 4,782 | 4,841 | 5,690 | 4,849 | 3,669 | 5,482 | 2,623 | 3,063 | 2,839 | 3,151 | 5,517 | 4,279 |
| Total Assets | 12,951 | 10,967 | 13,515 | 12,592 | 9,998 | 9,624 | 6,670 | 6,907 | 7,103 | 7,604 | 10,163 | 8,833 |
Below is a detailed analysis of the balance sheet data for Shree Renuka Sugars Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 213.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 213.00 Cr..
- For Reserves, as of Mar 2025, the value is -1,888.00 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -1,651.00 Cr. (Mar 2024) to -1,888.00 Cr., marking a decline of 237.00 Cr..
- For Borrowings, as of Mar 2025, the value is 5,889.00 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 5,794.00 Cr. (Mar 2024) to 5,889.00 Cr., marking an increase of 95.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 4,620.00 Cr.. The value appears to be improving (decreasing). It has decreased from 5,807.00 Cr. (Mar 2024) to 4,620.00 Cr., marking a decrease of 1,187.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 8,833.00 Cr.. The value appears to be improving (decreasing). It has decreased from 10,163.00 Cr. (Mar 2024) to 8,833.00 Cr., marking a decrease of 1,330.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 4,493.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,561.00 Cr. (Mar 2024) to 4,493.00 Cr., marking a decrease of 68.00 Cr..
- For CWIP, as of Mar 2025, the value is 21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 50.00 Cr. (Mar 2024) to 21.00 Cr., marking a decrease of 29.00 Cr..
- For Investments, as of Mar 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 34.00 Cr. (Mar 2024) to 40.00 Cr., marking an increase of 6.00 Cr..
- For Other Assets, as of Mar 2025, the value is 4,279.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,517.00 Cr. (Mar 2024) to 4,279.00 Cr., marking a decrease of 1,238.00 Cr..
- For Total Assets, as of Mar 2025, the value is 8,833.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10,163.00 Cr. (Mar 2024) to 8,833.00 Cr., marking a decrease of 1,330.00 Cr..
However, the Borrowings (5,889.00 Cr.) are higher than the Reserves (-1,888.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 916.00 | -210.00 | -293.00 | 361.00 | -9.00 | -3.00 | 57.00 | 567.00 | 396.00 | 585.00 | 680.00 | 604.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 20 | 22 | 27 | 31 | 44 | 23 | 10 | 10 | 16 | 8 | 20 | 15 |
| Inventory Days | 86 | 93 | 86 | 51 | 57 | 172 | 151 | 208 | 148 | 118 | 181 | 143 |
| Days Payable | 99 | 137 | 176 | 139 | 215 | 280 | 243 | 229 | 145 | 120 | 202 | 163 |
| Cash Conversion Cycle | 7 | -22 | -63 | -57 | -114 | -85 | -82 | -12 | 19 | 6 | -1 | -5 |
| Working Capital Days | -138 | -197 | -281 | -207 | -433 | -649 | -247 | -131 | -119 | -94 | -84 | -100 |
| ROCE % | -1% | -15% | -14% | -3% | -53% | -182% | 16% | 6% | 9% | 10% | 11% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Nifty Smallcap 250 Index Fund | 535,339 | 0.26 | 2.52 | 535,339 | 2025-04-22 17:25:20 | 0% |
| Motilal Oswal Nifty Smallcap 250 Index Fund | 334,542 | 0.26 | 1.58 | 334,542 | 2025-04-22 17:25:20 | 0% |
| Axis Nifty Smallcap 50 Index Fund | 332,887 | 0.78 | 1.57 | 332,887 | 2025-04-22 17:25:20 | 0% |
| SBI Nifty Smallcap 250 Index Fund | 262,590 | 0.26 | 1.24 | 262,590 | 2025-04-22 17:25:20 | 0% |
| Aditya Birla Sun Life Nifty Smallcap 50 Index Fund | 224,560 | 0.79 | 1.06 | 224,560 | 2025-04-22 17:25:20 | 0% |
| ICICI Prudential Nifty Smallcap 250 Index Fund | 124,996 | 0.26 | 0.59 | 124,996 | 2025-04-22 17:25:20 | 0% |
| HDFC NIFTY Smallcap 250 ETF | 72,536 | 0.26 | 0.34 | 72,536 | 2025-04-22 17:25:20 | 0% |
| Kotak Nifty Smallcap 50 Index | 69,562 | 0.78 | 0.33 | 69,562 | 2025-04-22 17:25:20 | 0% |
| HDFC Nifty Smallcap 250 Index Fund | 58,488 | 0.26 | 0.28 | 58,488 | 2025-04-22 17:25:20 | 0% |
| Motilal Oswal Nifty 500 Index Fund | 33,766 | 0.02 | 0.16 | 33,766 | 2025-04-22 17:25:20 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | -1.41 | -2.95 | -0.93 | -0.65 | -0.57 |
| Diluted EPS (Rs.) | -1.41 | -2.95 | -0.93 | -0.65 | -0.57 |
| Cash EPS (Rs.) | -0.09 | -1.70 | 0.19 | 0.33 | 0.43 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -7.87 | -6.75 | -4.14 | -2.85 | -3.12 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -7.87 | -6.75 | -4.14 | -2.85 | -3.12 |
| Revenue From Operations / Share (Rs.) | 49.81 | 53.18 | 42.38 | 30.22 | 26.54 |
| PBDIT / Share (Rs.) | 3.42 | 3.39 | 3.05 | 2.17 | 3.01 |
| PBIT / Share (Rs.) | 2.11 | 2.14 | 1.93 | 1.19 | 2.03 |
| PBT / Share (Rs.) | -1.70 | -2.17 | -0.84 | -0.65 | 0.24 |
| Net Profit / Share (Rs.) | -1.41 | -2.95 | -0.92 | -0.64 | -0.54 |
| NP After MI And SOA / Share (Rs.) | -1.41 | -2.95 | -0.92 | -0.65 | -0.53 |
| PBDIT Margin (%) | 6.86 | 6.38 | 7.19 | 7.18 | 11.34 |
| PBIT Margin (%) | 4.22 | 4.03 | 4.56 | 3.94 | 7.65 |
| PBT Margin (%) | -3.42 | -4.07 | -1.99 | -2.15 | 0.91 |
| Net Profit Margin (%) | -2.82 | -5.54 | -2.18 | -2.12 | -2.06 |
| NP After MI And SOA Margin (%) | -2.82 | -5.54 | -2.18 | -2.15 | -2.03 |
| Return on Capital Employeed (%) | 25.50 | 20.89 | 17.12 | 10.80 | 21.91 |
| Return On Assets (%) | -3.39 | -6.16 | -2.59 | -1.95 | -1.66 |
| Long Term Debt / Equity (X) | -1.87 | -2.25 | -3.47 | -4.54 | -3.87 |
| Total Debt / Equity (X) | -3.50 | -4.01 | -6.30 | -8.58 | -6.54 |
| Asset Turnover Ratio (%) | 1.12 | 1.27 | 1.23 | 0.87 | 0.80 |
| Current Ratio (X) | 0.59 | 0.67 | 0.58 | 0.57 | 0.60 |
| Quick Ratio (X) | 0.10 | 0.11 | 0.14 | 0.13 | 0.11 |
| Inventory Turnover Ratio (X) | 2.67 | 2.94 | 3.34 | 2.13 | 2.28 |
| Interest Coverage Ratio (X) | 0.89 | 0.78 | 1.10 | 1.18 | 1.67 |
| Interest Coverage Ratio (Post Tax) (X) | 0.63 | 0.31 | 0.66 | 0.65 | 0.68 |
| Enterprise Value (Cr.) | 11666.80 | 14173.82 | 14752.82 | 12705.74 | 6200.38 |
| EV / Net Operating Revenue (X) | 1.10 | 1.25 | 1.64 | 1.98 | 1.10 |
| EV / EBITDA (X) | 16.03 | 19.62 | 22.71 | 27.50 | 9.67 |
| MarketCap / Net Operating Revenue (X) | 0.55 | 0.74 | 1.04 | 1.18 | 0.34 |
| Price / BV (X) | -3.51 | -5.88 | -10.65 | -12.45 | -2.95 |
| Price / Net Operating Revenue (X) | 0.55 | 0.74 | 1.04 | 1.18 | 0.34 |
| EarningsYield | -0.05 | -0.07 | -0.02 | -0.01 | -0.05 |
After reviewing the key financial ratios for Shree Renuka Sugars Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -1.41. This value is below the healthy minimum of 5. It has increased from -2.95 (Mar 24) to -1.41, marking an increase of 1.54.
- For Diluted EPS (Rs.), as of Mar 25, the value is -1.41. This value is below the healthy minimum of 5. It has increased from -2.95 (Mar 24) to -1.41, marking an increase of 1.54.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.09. This value is below the healthy minimum of 3. It has increased from -1.70 (Mar 24) to -0.09, marking an increase of 1.61.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -7.87. It has decreased from -6.75 (Mar 24) to -7.87, marking a decrease of 1.12.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -7.87. It has decreased from -6.75 (Mar 24) to -7.87, marking a decrease of 1.12.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 49.81. It has decreased from 53.18 (Mar 24) to 49.81, marking a decrease of 3.37.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 3.42. This value is within the healthy range. It has increased from 3.39 (Mar 24) to 3.42, marking an increase of 0.03.
- For PBIT / Share (Rs.), as of Mar 25, the value is 2.11. This value is within the healthy range. It has decreased from 2.14 (Mar 24) to 2.11, marking a decrease of 0.03.
- For PBT / Share (Rs.), as of Mar 25, the value is -1.70. This value is below the healthy minimum of 0. It has increased from -2.17 (Mar 24) to -1.70, marking an increase of 0.47.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -1.41. This value is below the healthy minimum of 2. It has increased from -2.95 (Mar 24) to -1.41, marking an increase of 1.54.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -1.41. This value is below the healthy minimum of 2. It has increased from -2.95 (Mar 24) to -1.41, marking an increase of 1.54.
- For PBDIT Margin (%), as of Mar 25, the value is 6.86. This value is below the healthy minimum of 10. It has increased from 6.38 (Mar 24) to 6.86, marking an increase of 0.48.
- For PBIT Margin (%), as of Mar 25, the value is 4.22. This value is below the healthy minimum of 10. It has increased from 4.03 (Mar 24) to 4.22, marking an increase of 0.19.
- For PBT Margin (%), as of Mar 25, the value is -3.42. This value is below the healthy minimum of 10. It has increased from -4.07 (Mar 24) to -3.42, marking an increase of 0.65.
- For Net Profit Margin (%), as of Mar 25, the value is -2.82. This value is below the healthy minimum of 5. It has increased from -5.54 (Mar 24) to -2.82, marking an increase of 2.72.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -2.82. This value is below the healthy minimum of 8. It has increased from -5.54 (Mar 24) to -2.82, marking an increase of 2.72.
- For Return on Capital Employeed (%), as of Mar 25, the value is 25.50. This value is within the healthy range. It has increased from 20.89 (Mar 24) to 25.50, marking an increase of 4.61.
- For Return On Assets (%), as of Mar 25, the value is -3.39. This value is below the healthy minimum of 5. It has increased from -6.16 (Mar 24) to -3.39, marking an increase of 2.77.
- For Long Term Debt / Equity (X), as of Mar 25, the value is -1.87. This value is below the healthy minimum of 0.2. It has increased from -2.25 (Mar 24) to -1.87, marking an increase of 0.38.
- For Total Debt / Equity (X), as of Mar 25, the value is -3.50. This value is within the healthy range. It has increased from -4.01 (Mar 24) to -3.50, marking an increase of 0.51.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.12. It has decreased from 1.27 (Mar 24) to 1.12, marking a decrease of 0.15.
- For Current Ratio (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1.5. It has decreased from 0.67 (Mar 24) to 0.59, marking a decrease of 0.08.
- For Quick Ratio (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 1. It has decreased from 0.11 (Mar 24) to 0.10, marking a decrease of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.67. This value is below the healthy minimum of 4. It has decreased from 2.94 (Mar 24) to 2.67, marking a decrease of 0.27.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.89. This value is below the healthy minimum of 3. It has increased from 0.78 (Mar 24) to 0.89, marking an increase of 0.11.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 3. It has increased from 0.31 (Mar 24) to 0.63, marking an increase of 0.32.
- For Enterprise Value (Cr.), as of Mar 25, the value is 11,666.80. It has decreased from 14,173.82 (Mar 24) to 11,666.80, marking a decrease of 2,507.02.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.10. This value is within the healthy range. It has decreased from 1.25 (Mar 24) to 1.10, marking a decrease of 0.15.
- For EV / EBITDA (X), as of Mar 25, the value is 16.03. This value exceeds the healthy maximum of 15. It has decreased from 19.62 (Mar 24) to 16.03, marking a decrease of 3.59.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 1. It has decreased from 0.74 (Mar 24) to 0.55, marking a decrease of 0.19.
- For Price / BV (X), as of Mar 25, the value is -3.51. This value is below the healthy minimum of 1. It has increased from -5.88 (Mar 24) to -3.51, marking an increase of 2.37.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 1. It has decreased from 0.74 (Mar 24) to 0.55, marking a decrease of 0.19.
- For EarningsYield, as of Mar 25, the value is -0.05. This value is below the healthy minimum of 5. It has increased from -0.07 (Mar 24) to -0.05, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Shree Renuka Sugars Ltd:
- Net Profit Margin: -2.82%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 25.5% (Industry Average ROCE: 8.62%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 7.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.63
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.1
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 53.38)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -3.5
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -2.82%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Sugar | 2nd & 3rd Floor, Kanakashree Arcade, Belagavi Karnataka 590010 | groupcs@renukasugars.com http://www.renukasugars.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Atul Chaturvedi | Executive Chairman |
| Mr. Vijendra Singh | Executive Director & Deputy CEO |
| Mr. Ravi Gupta | Executive Director |
| Mr. Kuok Khoon Hong | Non Executive Director |
| Mr. Charles Cheau Leong Loo | Non Executive Director |
| Mr. Jean-Luc Bohbot | Non Executive Director |
| Mr. Madhu Rao | Independent Director |
| Dr. Bharat Kumar Mehta | Independent Director |
| Ms. Priyanka Mallick | Independent Director |
| Mr. Arun Chandra Verma | Independent Director |
| Mr. S Sridharan | Independent Director |
| Mr. Siraj Hussain | Independent Director |
| Mr. Tinniyan Kalyansundaram Kanan | Alternate Director |
FAQ
What is the intrinsic value of Shree Renuka Sugars Ltd?
Shree Renuka Sugars Ltd's intrinsic value (as of 19 October 2025) is 14.45 which is 50.51% lower the current market price of 29.20, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 6,217 Cr. market cap, FY2025-2026 high/low of 45.1/24.7, reserves of ₹-1,888 Cr, and liabilities of 8,833 Cr.
What is the Market Cap of Shree Renuka Sugars Ltd?
The Market Cap of Shree Renuka Sugars Ltd is 6,217 Cr..
What is the current Stock Price of Shree Renuka Sugars Ltd as on 19 October 2025?
The current stock price of Shree Renuka Sugars Ltd as on 19 October 2025 is 29.2.
What is the High / Low of Shree Renuka Sugars Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Shree Renuka Sugars Ltd stocks is 45.1/24.7.
What is the Stock P/E of Shree Renuka Sugars Ltd?
The Stock P/E of Shree Renuka Sugars Ltd is .
What is the Book Value of Shree Renuka Sugars Ltd?
The Book Value of Shree Renuka Sugars Ltd is 7.87.
What is the Dividend Yield of Shree Renuka Sugars Ltd?
The Dividend Yield of Shree Renuka Sugars Ltd is 0.00 %.
What is the ROCE of Shree Renuka Sugars Ltd?
The ROCE of Shree Renuka Sugars Ltd is 10.6 %.
What is the ROE of Shree Renuka Sugars Ltd?
The ROE of Shree Renuka Sugars Ltd is %.
What is the Face Value of Shree Renuka Sugars Ltd?
The Face Value of Shree Renuka Sugars Ltd is 1.00.